Recombinant Interleukin-13

**Semantic type:** Amino Acid, Peptide, or Protein|Pharmacologic Substance

**Definition:** The recombinant analogue of an endogenous cytokine interleukin 13 with potential antineoplastic activity. Produced by lymphocytes and exhibiting a variety of functions, interleukin-13 (therapeutic) inhibits DNA synthesis and regulates inflammatory and immune responses. In animal models, this agent has been shown to kill tumor cells both directly and indirectly by activating the host immune system at the tumor site. (NCI04)

**Synonyms:** - IL-13 - Interleukin 13